𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rescuing the BMPR2 signaling axis in pulmonary arterial hypertension

✍ Scribed by West, James; Austin, Eric; Fessel, Joshua P.; Loyd, James; Hamid, Rizwan


Book ID
122311430
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
499 KB
Volume
19
Category
Article
ISSN
1359-6446

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Mutations of the TGF-Ξ² type II receptor
✍ Rajiv D. Machado; Micheala A. Aldred; Victoria James; Rachel E. Harrison; Bhakti πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 315 KB

## Communicated by Maria Rita Passos-Bueno Pulmonary arterial hypertension (PAH) is clinically characterized by a sustained elevation in mean pulmonary artery pressure leading to significant morbidity and mortality. The disorder is typically sporadic, and in such cases the term idiopathic PAH (IPAH

BMPR2 mutation in a patient with pulmona
✍ Christina M. Rigelsky; Constance Jennings; Rainer Lehtonen; Omar A. Minai; Chari πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 140 KB πŸ‘ 1 views

## Abstract Pulmonary arterial hypertension (PAH) and hereditary hemorrhagic telangiectasia (HHT) are distinct clinical entities caused by germline mutations in genes encoding members of the TGFΞ²/BMP superfamily: __BMPR2__ in PAH and __ACVRL1__, __ENG__, or __SMAD4__ in HHT. When PAH and HHT occasi

Penetrance of pulmonary arterial hyperte
✍ Rizwan Hamid; Joy D. Cogan; Lora K. Hedges; Eric Austin; John A Phillips III; Jo πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 273 KB

Familial pulmonary arterial hypertension (FPAH) is a progressive, fatal disease caused by mutations in the bone morphogenetic protein receptor type 2 gene (BMPR2). FPAH is inherited as an autosomal dominant trait, and shows incomplete penetrance in that many with BMPR2 mutations do not develop FPAH,